{"product_id":"starhealth-pestle-analysis","title":"Star Health and Allied Insurance PESTLE Analysis","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSkip the Research. Get the Strategy.\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eGet a strategic advantage with our concise PESTLE Analysis of Star Health and Allied Insurance—highlighting regulatory pressures, economic trends, tech disruption, and social shifts that will shape its market position; buy the full report to access actionable insights, charts, and recommendations you can use in investment or strategy decisions.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eolitical factors\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGovernment Health Mission Alignment\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eThe Indian government’s Ayushman Bharat drive, covering over 600 million beneficiaries by 2025, and renewed emphasis on universal health coverage create demand tailwinds for private insurers like Star Health; aligning strategy to national goals can unlock public-private partnership schemes and government-sponsored distribution channels. Such political backing supports higher insurance penetration—India’s health-insurance penetration rose to ~38% by 2024—benefiting Star Health’s growth and premium mobilization.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRegulatory Oversight by IRDAI\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eThe Insurance Regulatory and Development Authority of India has rolled out reforms boosting insurance density from 3.2% of GDP in 2019 to an estimated 3.9% by 2024, strengthening policyholder protection and product oversight, which affects Star Health’s product design and reserves. Political stability in India supports predictable regulatory timelines, enabling Star Health to plan multi-year capital allocations after its 2023 IPO raised about INR 6,000 crore. Any relaxation in foreign direct investment caps or ownership norms—FDI was allowed up to 74% in insurance—would directly influence Star Health’s ability to access foreign capital and pursue aggressive scaling. Ongoing IRDAI directives on solvency and claim ratios (industry combined ratio ~100–110% in 2023) remain key risk-management drivers for the company.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eTax Incentives for Policyholders\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eGovernment decisions on tax deductions under Section 80D—currently allowing up to Rs 25,000 (Rs 50,000 for seniors) and increased uptake after 2023 reforms—directly affect demand for Star Health’s retail policies; FY2024 retail premium growth of around 18% reflects this sensitivity. Maintaining or expanding these incentives remains a political lever that could further boost Star Health’s individual business, which contributed ~62% of gross written premium in FY2024. Conversely, fiscal shifts favoring broader social security spending could compress private health insurance penetration, slowing segmental growth and impacting margins.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGeopolitical Stability and Global Travel\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eAs an overseas travel insurer, Star Health is exposed to India's diplomatic ties and travel advisories; in 2024 outbound trips from India rose to ~35 million, supporting premium growth in travel insurance.\u003c\/p\u003e\n\u003cp\u003eFavorable bilateral agreements and visa facilitation—e.g., India-EU talks and 12 new visa pacts in 2023–24—boost cross-border movement and segment revenues.\u003c\/p\u003e\n\u003cp\u003eGeopolitical tensions (Russia-Ukraine, Middle East conflicts) and resulting advisories in 2024 caused temporary travel cuts, reducing travel-insurance claims frequency and new-policy uptake.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eOutbound trips ~35M in 2024 — tailwind for travel insurance\u003c\/li\u003e\n\u003cli\u003e12 new visa\/bilateral pacts in 2023–24 — improved market access\u003c\/li\u003e\n\u003cli\u003eGeopolitical conflicts in 2024 — episodic demand\/claims volatility\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePublic Health Infrastructure Investment\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cppolitical prioritization of healthcare infrastructure in india with government capital expenditure on health rising to inr lakh crore fy2024 and flagship schemes targeting tier city hospitals expands potential hospital tie-ups for star allied insurance enhancing its cashless network reach.\u003e\u003cpthis increased spending has improved facility quality and access health infrastructure mission investments raised district hospital capacity by over in star ability to offer comprehensive coverage previously underserved regions.\u003e\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eINR 2.84 lakh crore health capex FY2024\u003c\/li\u003e\n\u003cli\u003e12% district hospital capacity rise in 2023\u003c\/li\u003e\n\u003cli\u003eExpanded Tier 2\/3 hospital tie-up opportunities\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/pthis\u003e\u003c\/ppolitical\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePolicy Tailwinds \u0026amp; Travel Demand Propel Star Health Amid IRDAI, FDI Shifts\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003ePolitical support for universal health coverage (Ayushman Bharat ~600M beneficiaries by 2025) and rising health capex (INR 2.84 lakh crore FY2024) boosts Star Health’s market access; IRDAI reforms and 74% FDI cap affect capital \u0026amp; product strategy; tax incentives (Section 80D) and outbound travel (~35M trips in 2024) drive retail and travel premiums, while geopolitical tensions create episodic demand\/claims volatility.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eAyushman Bharat reach\u003c\/td\u003e\n\u003ctd\u003e~600M by 2025\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eHealth capex FY2024\u003c\/td\u003e\n\u003ctd\u003eINR 2.84L Cr\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFDI cap\u003c\/td\u003e\n\u003ctd\u003e74%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eOutbound trips 2024\u003c\/td\u003e\n\u003ctd\u003e~35M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eExplores how external macro-environmental factors uniquely affect Star Health and Allied Insurance across Political, Economic, Social, Technological, Environmental, and Legal dimensions, with each section backed by current data and trends to identify risks and opportunities for executives, consultants, and entrepreneurs.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eA concise PESTLE summary of Star Health and Allied Insurance that’s visually segmented for quick meeting reference, easily dropped into presentations, edited with region-specific notes, and shareable across teams to streamline risk discussions and strategic planning.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eE\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003economic factors\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRising Per Capita Income\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eRising per capita income in India—GDP per capita ~USD 2,600 in 2024 and a growing middle class projected at ~360 million by 2025—drives demand for premium health cover; disposable income growth (real private consumption rising ~6% YoY in 2023–24) pushes consumers toward quality care and inflation protection. Star Health captures this with diversified plans across income tiers, aiding premium growth (company gross written premium up ~12% in FY2023–24).\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMedical Inflation Trends\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003ePersistent medical inflation—India's healthcare inflation rose ~5.6% YoY in 2024 while surgery and diagnostic tariffs climbed 6–10%—forces Star Health to revise premiums and sum-insured; insurer filed 2024 premium rate adjustments across product lines to reflect higher unit costs.\u003c\/p\u003e \n\u003cp\u003eRising claim costs pushed Star Health's combined ratio pressure, requiring tighter loss-ratio management—company reported a retail loss ratio near 85% in FY2024, highlighting need to balance affordability with claim inflation.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eInterest Rate Fluctuations\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eStar Health’s large float and investments mean RBI rate moves materially affect net investment income; a 100 bps rise in yields on G-secs and AAA corporate bonds in 2023–24 lifted market yields to ~7.1–7.5%, compressing bond prices but raising new portfolio yields, while lower rates in 2020–21 reduced investment returns; economic cycles therefore directly influence returns on premiums held before claim payouts and overall profitability.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eEmployment Rates and Corporate Group Business\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eEconomic expansion raised India's urban employment rate to about 46.8% in 2024 Q4, boosting corporate hiring and demand for group health policies; Star Health's B2B book benefits as employers expand benefits to attract talent.\u003c\/p\u003e\n\u003cp\u003eIn FY2024 Star Health reported ~28% growth in group-premium revenue, reflecting corporate spend on employee health; a recessionary downturn could force firms to cut benefits or lower coverage limits.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eHigher employment → increased group policy uptake\u003c\/li\u003e\n\u003cli\u003eFY2024 group-premium growth ≈ 28%\u003c\/li\u003e\n\u003cli\u003eEconomic slowdown risk: reduced coverage limits\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCurrency Exchange Volatility\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eFluctuations in the INR affect Star Health’s cost of overseas medical treatments and travel insurance claims; INR weakened ~8% vs USD in 2022–2023 and moved 3–6% annually in 2024–2025, raising claim liabilities for foreign-denominated bills.\u003c\/p\u003e\n\u003cp\u003eFor Star Health's international travel segment, a weaker rupee increases payout amounts and reserve pressure—foreign claims can surge by similar percentages when USD\/INR moves sharply.\u003c\/p\u003e\n\u003cp\u003eEconomic stability is vital to predictability: volatile FX requires higher hedging or contingency reserves, impacting combined ratio and solvency margins.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eINR volatility: 3–8% annual swings (2022–2025)\u003c\/li\u003e\n\u003cli\u003eHigher claim liability when USD\/INR weakens\u003c\/li\u003e\n\u003cli\u003eNeed for hedging\/contingency reserves impacts solvency\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRising middle class and GDP drive premium growth amid medical inflation, margin squeeze\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eRising GDP per capita (~USD 2,600 in 2024) and a ~360m middle class by 2025 boost premium demand; GWP growth ~12% FY2023–24 and retail loss ratio ~85% indicate pricing pressure from medical inflation (~5.6% in 2024) and higher claim costs. Yield shifts (G-sec ~7.1–7.5% in 2023–24) affect investment income; group premiums grew ~28% in FY2024 while INR volatility (3–8% pa) raises foreign claim liabilities.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eGDP per capita (2024)\u003c\/td\u003e\n\u003ctd\u003e~USD 2,600\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMiddle class (2025 est.)\u003c\/td\u003e\n\u003ctd\u003e~360 million\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGWP growth (FY2023–24)\u003c\/td\u003e\n\u003ctd\u003e~12%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRetail loss ratio (FY2024)\u003c\/td\u003e\n\u003ctd\u003e~85%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMedical inflation (2024)\u003c\/td\u003e\n\u003ctd\u003e~5.6% YoY\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eG-sec yields (2023–24)\u003c\/td\u003e\n\u003ctd\u003e~7.1–7.5%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGroup premium growth (FY2024)\u003c\/td\u003e\n\u003ctd\u003e~28%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eINR volatility (2022–25)\u003c\/td\u003e\n\u003ctd\u003e~3–8% pa\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003ePreview Before You Purchase\u003c\/span\u003e\u003cbr\u003eStar Health and Allied Insurance PESTLE Analysis\u003c\/h2\u003e\n\u003cp\u003eThe preview shown here is the exact document you’ll receive after purchase—fully formatted and ready to use; it contains the complete PESTLE analysis for Star Health and Allied Insurance, covering political, economic, social, technological, legal, and environmental factors with actionable insights and data-driven observations.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":56751473426809,"sku":"starhealth-pestle-analysis","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/starhealth-pestle-analysis.png?v=1772231872","url":"https:\/\/matrixbcg.com\/products\/starhealth-pestle-analysis","provider":"MatrixBCG","version":"1.0","type":"link"}